PUBLISHER: Allied Market Research | PRODUCT CODE: 1566894
PUBLISHER: Allied Market Research | PRODUCT CODE: 1566894
Legionella Testing Kits Market By Type , By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
Legionella Testing Kits Market
The legionella testing kits market was valued at $324.0 million in 2023 and is projected to reach $684.5 million by 2033, growing at a CAGR of 7.7% from 2024 to 2033.
A legionella testing kit is a rapid do-it-yourself tester which enables detection of the bacteria Legionella. This kit is essentially used in spaces such as care homes & hospitals, hospitality, pools & fountains, and cooling towers. The testing is performed using diverse biomolecular processes such as culture method, polymerase chain reaction technique, or immunological assay. The key attributes of the kit include short turnaround time, high precision, and ease of usage.
Increase in awareness about the prevention of water borne diseases is a key driver of the legionella testing kits market. Commercial and public buildings have strengthened their regulations regarding public safety, boosting the adoption of testing kits. In addition, advancements in technology have enhanced the efficacy and reliability of the kits, thereby augmenting the development of the market. In recent times, quick delivery of results and integration of the kits with digital solutions are the prominent trends acquiring traction. To facilitate seamless analysis and reporting of test results, manufacturers are designing kits with the ability to be assimilated with digital data management systems. This integration assists in tracking the patterns of water quality & safety and making effective decisions.
However, the cost of advanced version of kits with high precision and accuracy remains significantly high, restricting small organizations from purchasing them. Furthermore, the collection and handling of the sample & kit is a complex process which requires training & practice. Slight contamination of the kit impacts its reliability, thereby hampering the growth of the market. Contrarily, efforts by governments to conduct periodic water testing in public places and buildings are presenting lucrative opportunities for the market. For instance, the U.S. General Service Administration conducted water testing across several federal buildings in January 2024 to ensure the wellness of individuals visiting and working in the buildings.
Segment Review
The legionella testing kits market is segmented into type, end user, and region. On the basis of type, the market is divided into culture media, urine antigen testing, polymerase chain reaction, serology, and direct fluorescent antibody test. Depending on end user, it is classified into hospitals & clinics, clinical laboratories, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of type, the polymerase chain reaction segment accounted for the largest share in 2023.
Depending on end user, the hospitals & clinics segment acquired a high stake in the market in 2023.
Region wise, North America was the highest revenue generator in 2023.
Competition Analysis
The leading players operating in the global legionella testing kits market include IDEXX Laboratories, Inc., Thermo Fisher Scientific, Merck Group KGaA, Pall Corporation, Bio-Rad Laboratories, Inc., Abbott Laboratories, Hygiena, Veolia Water Technologies, Pro-Lab Diagnostics, and phigenics, llc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Additional company profiles with specific to client's interest
Key Market Segments
By Type
- Culture Media
- Urine Antigen Testing
- Polymerase Chain Reaction
- Serology
- Direct Fluorescent Antibody Test
By End User
- Hospitals and Clinics
- Clinical Laboratories
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
Key Market Players:
- IDEXX Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Merck Group KGaA
- Pall Corporation
- Bio-Rad Laboratories, Inc.
- Abbott Laboratories
- Hygiena
- Veolia Water Technologies
- Pro-Lab Diagnostics
- Phigenics, LLC
TABLE OF CONTENTS
CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
CHAPTER 4: LEGIONELLA TESTING KITS MARKET, BY TYPE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Type
- 4.2. Culture Media
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Urine Antigen Testing
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Polymerase Chain Reaction
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- 4.5. Serology
- 4.5.1. Key Market Trends, Growth Factors and Opportunities
- 4.5.2. Market Size and Forecast, By Region
- 4.5.3. Market Share Analysis, By Country
- 4.6. Direct Fluorescent Antibody Test
- 4.6.1. Key Market Trends, Growth Factors and Opportunities
- 4.6.2. Market Size and Forecast, By Region
- 4.6.3. Market Share Analysis, By Country
CHAPTER 5: LEGIONELLA TESTING KITS MARKET, BY END USER
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By End User
- 5.2. Hospitals And Clinics
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Clinical Laboratories
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Others
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
CHAPTER 6: LEGIONELLA TESTING KITS MARKET, BY REGION
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Region
- 6.2. North America
- 6.2.1. Key Market Trends and Opportunities
- 6.2.2. Market Size and Forecast, By Type
- 6.2.3. Market Size and Forecast, By End User
- 6.2.4. Market Size and Forecast, By Country
- 6.2.5. U.S. Legionella Testing Kits Market
- 6.2.5.1. Market Size and Forecast, By Type
- 6.2.5.2. Market Size and Forecast, By End User
- 6.2.6. Canada Legionella Testing Kits Market
- 6.2.6.1. Market Size and Forecast, By Type
- 6.2.6.2. Market Size and Forecast, By End User
- 6.2.7. Mexico Legionella Testing Kits Market
- 6.2.7.1. Market Size and Forecast, By Type
- 6.2.7.2. Market Size and Forecast, By End User
- 6.3. Europe
- 6.3.1. Key Market Trends and Opportunities
- 6.3.2. Market Size and Forecast, By Type
- 6.3.3. Market Size and Forecast, By End User
- 6.3.4. Market Size and Forecast, By Country
- 6.3.5. France Legionella Testing Kits Market
- 6.3.5.1. Market Size and Forecast, By Type
- 6.3.5.2. Market Size and Forecast, By End User
- 6.3.6. Germany Legionella Testing Kits Market
- 6.3.6.1. Market Size and Forecast, By Type
- 6.3.6.2. Market Size and Forecast, By End User
- 6.3.7. Italy Legionella Testing Kits Market
- 6.3.7.1. Market Size and Forecast, By Type
- 6.3.7.2. Market Size and Forecast, By End User
- 6.3.8. Spain Legionella Testing Kits Market
- 6.3.8.1. Market Size and Forecast, By Type
- 6.3.8.2. Market Size and Forecast, By End User
- 6.3.9. UK Legionella Testing Kits Market
- 6.3.9.1. Market Size and Forecast, By Type
- 6.3.9.2. Market Size and Forecast, By End User
- 6.3.10. Rest of Europe Legionella Testing Kits Market
- 6.3.10.1. Market Size and Forecast, By Type
- 6.3.10.2. Market Size and Forecast, By End User
- 6.4. Asia-Pacific
- 6.4.1. Key Market Trends and Opportunities
- 6.4.2. Market Size and Forecast, By Type
- 6.4.3. Market Size and Forecast, By End User
- 6.4.4. Market Size and Forecast, By Country
- 6.4.5. China Legionella Testing Kits Market
- 6.4.5.1. Market Size and Forecast, By Type
- 6.4.5.2. Market Size and Forecast, By End User
- 6.4.6. Japan Legionella Testing Kits Market
- 6.4.6.1. Market Size and Forecast, By Type
- 6.4.6.2. Market Size and Forecast, By End User
- 6.4.7. India Legionella Testing Kits Market
- 6.4.7.1. Market Size and Forecast, By Type
- 6.4.7.2. Market Size and Forecast, By End User
- 6.4.8. South Korea Legionella Testing Kits Market
- 6.4.8.1. Market Size and Forecast, By Type
- 6.4.8.2. Market Size and Forecast, By End User
- 6.4.9. Australia Legionella Testing Kits Market
- 6.4.9.1. Market Size and Forecast, By Type
- 6.4.9.2. Market Size and Forecast, By End User
- 6.4.10. Rest of Asia-Pacific Legionella Testing Kits Market
- 6.4.10.1. Market Size and Forecast, By Type
- 6.4.10.2. Market Size and Forecast, By End User
- 6.5. LAMEA
- 6.5.1. Key Market Trends and Opportunities
- 6.5.2. Market Size and Forecast, By Type
- 6.5.3. Market Size and Forecast, By End User
- 6.5.4. Market Size and Forecast, By Country
- 6.5.5. Brazil Legionella Testing Kits Market
- 6.5.5.1. Market Size and Forecast, By Type
- 6.5.5.2. Market Size and Forecast, By End User
- 6.5.6. South Africa Legionella Testing Kits Market
- 6.5.6.1. Market Size and Forecast, By Type
- 6.5.6.2. Market Size and Forecast, By End User
- 6.5.7. Saudi Arabia Legionella Testing Kits Market
- 6.5.7.1. Market Size and Forecast, By Type
- 6.5.7.2. Market Size and Forecast, By End User
- 6.5.8. Rest of LAMEA Legionella Testing Kits Market
- 6.5.8.1. Market Size and Forecast, By Type
- 6.5.8.2. Market Size and Forecast, By End User
CHAPTER 7: COMPETITIVE LANDSCAPE
- 7.1. Introduction
- 7.2. Top Winning Strategies
- 7.3. Product Mapping of Top 10 Player
- 7.4. Competitive Dashboard
- 7.5. Competitive Heatmap
- 7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
- 8.1. IDEXX Laboratories, Inc.
- 8.1.1. Company Overview
- 8.1.2. Key Executives
- 8.1.3. Company Snapshot
- 8.1.4. Operating Business Segments
- 8.1.5. Product Portfolio
- 8.1.6. Business Performance
- 8.1.7. Key Strategic Moves and Developments
- 8.2. Thermo Fisher Scientific
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Operating Business Segments
- 8.2.5. Product Portfolio
- 8.2.6. Business Performance
- 8.2.7. Key Strategic Moves and Developments
- 8.3. Merck Group KGaA
- 8.3.1. Company Overview
- 8.3.2. Key Executives
- 8.3.3. Company Snapshot
- 8.3.4. Operating Business Segments
- 8.3.5. Product Portfolio
- 8.3.6. Business Performance
- 8.3.7. Key Strategic Moves and Developments
- 8.4. Pall Corporation
- 8.4.1. Company Overview
- 8.4.2. Key Executives
- 8.4.3. Company Snapshot
- 8.4.4. Operating Business Segments
- 8.4.5. Product Portfolio
- 8.4.6. Business Performance
- 8.4.7. Key Strategic Moves and Developments
- 8.5. Bio-Rad Laboratories, Inc.
- 8.5.1. Company Overview
- 8.5.2. Key Executives
- 8.5.3. Company Snapshot
- 8.5.4. Operating Business Segments
- 8.5.5. Product Portfolio
- 8.5.6. Business Performance
- 8.5.7. Key Strategic Moves and Developments
- 8.6. Abbott Laboratories
- 8.6.1. Company Overview
- 8.6.2. Key Executives
- 8.6.3. Company Snapshot
- 8.6.4. Operating Business Segments
- 8.6.5. Product Portfolio
- 8.6.6. Business Performance
- 8.6.7. Key Strategic Moves and Developments
- 8.7. Hygiena
- 8.7.1. Company Overview
- 8.7.2. Key Executives
- 8.7.3. Company Snapshot
- 8.7.4. Operating Business Segments
- 8.7.5. Product Portfolio
- 8.7.6. Business Performance
- 8.7.7. Key Strategic Moves and Developments
- 8.8. Veolia Water Technologies
- 8.8.1. Company Overview
- 8.8.2. Key Executives
- 8.8.3. Company Snapshot
- 8.8.4. Operating Business Segments
- 8.8.5. Product Portfolio
- 8.8.6. Business Performance
- 8.8.7. Key Strategic Moves and Developments
- 8.9. Pro-Lab Diagnostics
- 8.9.1. Company Overview
- 8.9.2. Key Executives
- 8.9.3. Company Snapshot
- 8.9.4. Operating Business Segments
- 8.9.5. Product Portfolio
- 8.9.6. Business Performance
- 8.9.7. Key Strategic Moves and Developments
- 8.10. Phigenics, LLC
- 8.10.1. Company Overview
- 8.10.2. Key Executives
- 8.10.3. Company Snapshot
- 8.10.4. Operating Business Segments
- 8.10.5. Product Portfolio
- 8.10.6. Business Performance
- 8.10.7. Key Strategic Moves and Developments
